October 16, 2014 Blog Myriad Back in Court on Patent Subject Matter Eligibility On June 13, 2013, the Supreme Court issued a unanimous decision holding that “genes and the information they encode are ... Read More
April 17, 2013 Blog After Patent Life, FDA says NO to Generic OxyContin After Patent Life, FDA says NO to Generic OxyContin Background Under the Food, Drug, & Cosmetic (FD&C) Act and implementing ... Read More